ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced

Jordi Remon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.